Graham Partners - Private Equity Firm Profile | CT Acquisitions Directory - CT Acquisitions

Firm at a glance

Graham Partners is a platform private equity firm founded in 1988 and headquartered in Newtown Square, PA, per its own website [S1]. The firm reported approximately $5.0 billion in regulatory assets under management as of March 31, 2026 [S2].

What they buy

Graham Partners’ portfolio demonstrates a pattern of acquiring businesses in medical devices and life sciences, food and consumer essentials, and industrial technology sectors [S3]. Recent platform investments include Quantive Intelligence in medical devices (July 2026), Target Flavors in food ingredients (November 2025), and Becklar in industrial technology (December 2024) [S3]. The firm appears to pursue both platform acquisitions and add-on transactions to support portfolio company growth, with at least one add-on completed in the last 12 months [S3].

Portfolio

Medical Devices & Life Sciences

Quantive Intelligence (platform, July 2026), Midwest Products & Engineering (April 2026), and Smithstown Light Engineering (July 2025) [S3].

Food & Consumer Essentials

Target Flavors (platform, November 2025), Miss Jones Baking Co (May 2025), Tulkoff Foods (October 2024), Bite (February 2024), and Commercial Bakeries (September 2023) [S3].

Industrial Technology

Becklar (platform, December 2024) and E Tech Group (April 2024) [S3].

Recent activity (last 24 months)

* July 2026: Acquired Quantive Intelligence [S3]
* June 2026: Completed add-on acquisition of Legacy Security Services [S4]
* April 2026: Acquired Midwest Products & Engineering [S3]
* November 2025: Acquired Target Flavors [S3]
* July 2025: Acquired Smithstown Light Engineering [S3]
* May 2025: Acquired Miss Jones Baking Co [S3]
* December 2024: Acquired Becklar [S3]
* October 2024: Acquired Tulkoff Foods [S3]
* June 2024: Exited Creative Mines [S4]
* April 2024: Acquired E Tech Group [S3]

How this firm fits a seller

Graham Partners appears to pursue a platform-focused strategy, establishing new portfolio companies and subsequently building them through add-on acquisitions [S3]. The firm’s transaction history shows active deal execution across multiple sectors, with eight platform or add-on acquisitions completed in the trailing 24 months [S3][S4]. For owner-operators in medical devices, food manufacturing, or industrial technology, Graham Partners represents a potential buyer with demonstrated sector experience and a track record of supporting portfolio companies through acquisition-driven growth. The firm’s June 2024 exit of Creative Mines indicates an active realization program alongside new investment activity [S4].

Sources

[S1] https://www.grahampartners.net (as of 2026-03-31)
[S2] https://www.grahampartners.net/about-us/ (as of 2026-03-31)
[S3] https://www.grahampartners.net/portfolio/ (as of 2026-03-31)
[S4] https://www.grahampartners.net (as of 2026-03-31)

Frequently asked questions

Does Graham Partners buy Medical Devices & Life Sciences businesses?

Yes, Graham Partners has demonstrated active investment in medical devices and life sciences companies. The firm acquired three businesses in this sector within the past 12 months, including Quantive Intelligence as a platform in July 2026, Midwest Products & Engineering in April 2026, and Smithstown Light Engineering in July 2025 [S3].

What companies has Graham Partners acquired recently?

Graham Partners’ most recent acquisitions include Quantive Intelligence in July 2026, Midwest Products & Engineering in April 2026, and Target Flavors in November 2025 [S3]. The firm also completed an add-on acquisition of Legacy Security Services in June 2026 [S4].

Where is Graham Partners based and how big is the firm?

Graham Partners is based in Newtown Square, PA [S1]. The firm reported approximately $5.0 billion in regulatory assets under management as of March 31, 2026 [S2].

Is Graham Partners still actively acquiring?

Yes, Graham Partners appears to be actively acquiring businesses. The firm completed its most recent platform acquisition of Quantive Intelligence in July 2026 and an add-on transaction in June 2026, indicating ongoing investment activity [S3][S4].

This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.